Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...
Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...
Agentiiv – a pioneer in enterprise-grade, agentic AI systems in Canada – today announced a technology partnership with the Vector Institute. As a Vector technology partner, Agentiiv gains access to ...
Introgen Therapeutic’s (Austin, TX) p53-based INGN 225 cancer vaccine yielded promising safety and efficacy results in a Phase II trial in advanced small cell lung cancer. The personalized therapeutic ...
(RTTNews) - Sarepta Therapeutics (SRPT), Wednesday announced that the FDA has designated its rAAVrh74 viral vector used in the investigational gene therapy SRP-9003 for limb-girdle muscular dystrophy ...
Integration with leading vector database enables ease of adoption within the open-source community and taking full advantage of SSD-optimized vector search capabilities TOKYO--(BUSINESS WIRE)--Kioxia ...
IonQ said Wednesday the planned acquisition is intended to expand its quantum technology portfolio. By integrating Vector Atomic’s advanced PNT systems, including rackmount optical atomic clocks, ...
IonQ, a quantum computing technology company, has finalized the acquisition of quantum sensing firm Vector Atomic. IonQ said Tuesday the all-stock transaction enhances its position as a full-spectrum ...
On Tuesday, Adobe announced major updates to AI image synthesis features across several products, including Photoshop, Illustrator, and Adobe Express. The updates include three new generative AI ...
Unity is undervalued and poised for growth due to its AI-driven Vector model for advertising targeting and a user-friendly Create business model. Despite recent market turmoil, Unity's technology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results